Farther Finance Advisors LLC Buys 16,164 Shares of Kenvue Inc. $KVUE

Key Points

• Farther Finance Advisors LLC increased its holdings in Kenvue Inc. by 80.7% in Q2, owning a total of 36,196 shares valued at $758,000 after purchasing an additional 16,164 shares.
• Kenvue reported a net income of $0.29 per share for the quarter, exceeding analysts' expectations, but faced a 4.0% decline in year-over-year revenue.
• Kenvue recently increased its quarterly dividend to $0.2075 per share, providing a yield of 5.1%, despite a dividend payout ratio of 112.16%.

Farther Finance Advisors LLC grew its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 80.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 36,196 shares of the company's stock after buying an additional 16,164 shares during the quarter. Farther Finance Advisors LLC's holdings in Kenvue were worth $758,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Pittenger & Anderson Inc. bought a new position in shares of Kenvue during the first quarter valued at approximately $30,000. TruNorth Capital Management LLC bought a new position in shares of Kenvue during the first quarter valued at approximately $36,000. Truvestments Capital LLC bought a new position in shares of Kenvue during the first quarter valued at approximately $37,000. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock valued at $39,000 after buying an additional 1,287 shares during the last quarter. Finally, Bank Julius Baer & Co. Ltd Zurich grew its stake in shares of Kenvue by 120.6% during the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company's stock valued at $41,000 after buying an additional 929 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Kenvue Stock Down 3.9%

Kenvue stock opened at $16.20 on Friday. The business has a fifty day moving average of $20.48 and a two-hundred day moving average of $21.88. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The firm has a market cap of $31.09 billion, a P/E ratio of 21.89, a P/E/G ratio of 2.42 and a beta of 0.83. Kenvue Inc. has a twelve month low of $16.14 and a twelve month high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue's revenue was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were issued a dividend of $0.2075 per share. This is an increase from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a yield of 5.1%. The ex-dividend date was Wednesday, August 13th. Kenvue's dividend payout ratio (DPR) is currently 112.16%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Evercore ISI cut their target price on Kenvue from $23.00 to $18.00 and set an "in-line" rating on the stock in a research note on Tuesday. Citigroup reissued a "neutral" rating on shares of Kenvue in a research note on Tuesday. Zacks Research raised Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Royal Bank Of Canada dropped their price objective on Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research note on Friday, August 8th. Finally, Canaccord Genuity Group dropped their price objective on Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Four analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $23.32.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.